Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Aravindhan Veerapandiyan

Concepts (225)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscular Dystrophy, Duchenne
12
2026
30
4.800
Why?
Muscular Atrophy, Spinal
5
2024
14
2.860
Why?
Genetic Therapy
9
2026
127
2.410
Why?
Oligonucleotides
4
2020
76
1.960
Why?
Pneumonia, Viral
3
2020
175
1.550
Why?
Coronavirus Infections
3
2020
188
1.530
Why?
Spastic Paraplegia, Hereditary
2
2022
4
1.480
Why?
Mutation
12
2023
1331
1.420
Why?
Disease Management
2
2020
185
1.160
Why?
Dystonic Disorders
2
2023
7
1.130
Why?
Pandemics
4
2022
580
1.070
Why?
Child
26
2026
7195
1.040
Why?
Humans
54
2026
52459
1.010
Why?
Morpholinos
1
2025
2
0.940
Why?
Spasms, Infantile
2
2018
31
0.900
Why?
Epilepsy
2
2022
191
0.880
Why?
Recombinant Fusion Proteins
3
2026
177
0.870
Why?
Neuromuscular Diseases
1
2024
31
0.840
Why?
Spinal Muscular Atrophies of Childhood
2
2020
9
0.820
Why?
Intellectual Disability
2
2022
127
0.820
Why?
Peroneal Neuropathies
2
2021
5
0.810
Why?
Dystrophin
4
2026
7
0.800
Why?
Adolescent
19
2026
6714
0.800
Why?
Dystonia
1
2023
12
0.790
Why?
Male
32
2026
26882
0.750
Why?
Nerve Tissue Proteins
2
2021
201
0.740
Why?
Child, Preschool
15
2026
4046
0.730
Why?
Myasthenic Syndromes, Congenital
1
2021
8
0.710
Why?
Chromosomes, Human, Pair 22
2
2011
38
0.680
Why?
Seizures
3
2018
201
0.670
Why?
Fasciculation
1
2020
2
0.670
Why?
Isaacs Syndrome
1
2020
2
0.670
Why?
Hereditary Sensory and Motor Neuropathy
1
2020
3
0.670
Why?
Muscular Dystrophies
1
2020
15
0.650
Why?
Myopathies, Structural, Congenital
1
2020
10
0.650
Why?
Codon, Nonsense
1
2020
28
0.650
Why?
Consensus
2
2024
195
0.640
Why?
Anticonvulsants
2
2012
136
0.640
Why?
Apoptosis Regulatory Proteins
1
2020
84
0.630
Why?
Glucocorticoids
3
2020
234
0.630
Why?
Charcot-Marie-Tooth Disease
1
2019
7
0.630
Why?
Epstein-Barr Virus Infections
1
2020
31
0.620
Why?
Phenotype
3
2020
792
0.620
Why?
Encephalitis
2
2017
39
0.600
Why?
Adaptor Proteins, Signal Transducing
1
2020
202
0.600
Why?
Infant
9
2020
3712
0.590
Why?
Multiple Sclerosis
1
2019
72
0.580
Why?
Chromosome Duplication
1
2018
6
0.580
Why?
Survival of Motor Neuron 1 Protein
1
2018
3
0.580
Why?
Munc18 Proteins
1
2018
3
0.570
Why?
Spinal Puncture
1
2018
17
0.570
Why?
Electroencephalography
6
2018
301
0.570
Why?
Microfilament Proteins
1
2018
44
0.560
Why?
Epilepsies, Myoclonic
1
2018
15
0.560
Why?
Attention Deficit Disorder with Hyperactivity
2
2024
177
0.550
Why?
Chromosomes, Human, Pair 1
1
2018
95
0.550
Why?
Head
1
2018
70
0.550
Why?
Chromosome Deletion
3
2018
138
0.530
Why?
Delivery of Health Care
1
2020
317
0.530
Why?
Central Nervous System Diseases
1
2017
25
0.520
Why?
Pedigree
3
2022
126
0.520
Why?
Dependovirus
3
2026
104
0.490
Why?
Carrier Proteins
1
2018
312
0.490
Why?
Muscular Diseases
2
2020
60
0.480
Why?
Female
21
2026
28286
0.450
Why?
DiGeorge Syndrome
2
2012
18
0.430
Why?
Emergency Service, Hospital
1
2018
521
0.430
Why?
Tomography, X-Ray Computed
1
2018
1141
0.390
Why?
Brain
2
2018
1338
0.380
Why?
Epilepsy, Complex Partial
1
2012
3
0.370
Why?
Carbamazepine
1
2012
13
0.370
Why?
Epilepsy, Tonic-Clonic
1
2011
3
0.350
Why?
Pyridoxal Phosphate
1
2011
10
0.340
Why?
Cephalometry
1
2011
18
0.340
Why?
Myoglobinuria
1
2010
2
0.340
Why?
Triazines
1
2011
25
0.340
Why?
Treatment Outcome
6
2026
5508
0.340
Why?
Ocular Motility Disorders
1
2011
16
0.340
Why?
Epilepsy, Absence
1
2011
11
0.340
Why?
Velopharyngeal Insufficiency
1
2011
18
0.330
Why?
BRCA2 Protein
1
2010
18
0.330
Why?
Pseudolymphoma
1
2010
4
0.330
Why?
Prednisolone
3
2020
56
0.330
Why?
Retrospective Studies
7
2021
6695
0.330
Why?
Mutation, Missense
1
2010
108
0.320
Why?
Drug Overdose
1
2011
161
0.290
Why?
Genetic Vectors
2
2026
128
0.280
Why?
Diagnosis, Differential
3
2020
1029
0.280
Why?
Myocarditis
2
2024
49
0.260
Why?
Young Adult
7
2024
4349
0.250
Why?
Liver Failure, Acute
1
2026
56
0.230
Why?
Insurance Claim Review
1
2025
41
0.230
Why?
Follow-Up Studies
3
2021
2294
0.230
Why?
Muscle, Skeletal
1
2010
799
0.230
Why?
Drug Therapy, Combination
2
2020
404
0.230
Why?
Gene Transfer Techniques
1
2024
44
0.220
Why?
Heterozygote
2
2023
89
0.220
Why?
United States
3
2025
5215
0.210
Why?
Heart-Assist Devices
1
2026
155
0.210
Why?
Mental Disorders
2
2024
427
0.200
Why?
Histone-Lysine N-Methyltransferase
1
2023
56
0.190
Why?
Magnetic Resonance Imaging
3
2018
1508
0.190
Why?
Adenosine Triphosphatases
1
2022
91
0.180
Why?
Adult
8
2024
14212
0.180
Why?
Semaphorins
1
2021
5
0.180
Why?
Atrophy
1
2022
46
0.180
Why?
Heart Transplantation
1
2026
320
0.180
Why?
Patient Care Planning
1
2022
68
0.180
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2021
4
0.170
Why?
Cell Adhesion Molecules
1
2021
89
0.170
Why?
Receptors, Cell Surface
1
2021
111
0.170
Why?
Cohort Studies
2
2018
1579
0.170
Why?
Introns
2
2018
53
0.160
Why?
Muscle Cramp
1
2020
5
0.160
Why?
Recovery of Function
1
2021
201
0.160
Why?
Palliative Care
1
2022
194
0.160
Why?
Flavoproteins
1
2019
5
0.160
Why?
Injections, Spinal
1
2019
22
0.160
Why?
Health Services Accessibility
1
2024
444
0.160
Why?
Heart Failure
1
2026
527
0.160
Why?
Phosphoric Monoester Hydrolases
1
2019
23
0.160
Why?
Hand Strength
1
2019
25
0.160
Why?
Physical Endurance
1
2019
35
0.160
Why?
Facial Paralysis
1
2020
25
0.160
Why?
Muscle Weakness
1
2020
45
0.150
Why?
Neurologic Examination
1
2019
73
0.150
Why?
Membrane Proteins
1
2022
344
0.150
Why?
Age of Onset
1
2019
109
0.150
Why?
Steroids
1
2019
61
0.150
Why?
Abnormalities, Multiple
2
2011
164
0.150
Why?
Age Factors
3
2018
1120
0.150
Why?
Scoliosis
1
2019
60
0.150
Why?
Spinal Fusion
1
2019
70
0.150
Why?
Aminomethyltransferase
1
2018
1
0.150
Why?
Hyperglycinemia, Nonketotic
1
2018
5
0.150
Why?
Hyperammonemia
1
2018
23
0.150
Why?
Activities of Daily Living
1
2019
185
0.140
Why?
Lumbosacral Region
1
2018
13
0.140
Why?
X-Rays
1
2018
55
0.140
Why?
Anti-Inflammatory Agents
1
2019
166
0.140
Why?
Neuraminidase
1
2018
4
0.140
Why?
Mucolipidoses
1
2018
4
0.140
Why?
Pons
1
2017
33
0.130
Why?
Methylprednisolone
1
2017
40
0.130
Why?
Brain Stem
1
2017
56
0.130
Why?
Prevalence
1
2020
1016
0.130
Why?
Disease Progression
1
2019
870
0.130
Why?
Cross-Sectional Studies
2
2019
1676
0.120
Why?
Quality of Life
1
2022
893
0.120
Why?
Middle Aged
4
2024
13136
0.120
Why?
T-Lymphocytes
1
2017
318
0.110
Why?
Chronic Disease
1
2017
579
0.110
Why?
RNA, Messenger
1
2018
1134
0.110
Why?
Aged
3
2021
10243
0.110
Why?
Antibodies
2
2012
144
0.110
Why?
Kv1.1 Potassium Channel
1
2013
2
0.100
Why?
Dipeptides
1
2012
21
0.090
Why?
Caregivers
2
2024
239
0.090
Why?
Aspartic Acid
1
2012
49
0.090
Why?
Folic Acid Deficiency
1
2012
43
0.090
Why?
Folate Receptor 1
1
2012
27
0.090
Why?
Prefrontal Cortex
1
2012
85
0.090
Why?
Ear
1
2011
15
0.090
Why?
Hypoparathyroidism
1
2011
5
0.090
Why?
Immune System Diseases
1
2011
9
0.090
Why?
Facies
1
2011
36
0.090
Why?
Eye Abnormalities
1
2011
24
0.090
Why?
Nose
1
2011
33
0.090
Why?
Epilepsies, Partial
1
2011
15
0.090
Why?
Platybasia
1
2011
5
0.090
Why?
Frontal Lobe
1
2011
46
0.090
Why?
Infant, Newborn
1
2018
2876
0.080
Why?
Receptors, N-Methyl-D-Aspartate
1
2011
126
0.080
Why?
Glycogen Storage Disease Type III
1
2010
1
0.080
Why?
Glycogen Debranching Enzyme System
1
2010
2
0.080
Why?
Cervical Vertebrae
1
2011
61
0.080
Why?
Genetic Heterogeneity
1
2010
20
0.080
Why?
Genetic Predisposition to Disease
1
2013
525
0.080
Why?
Brain Mapping
1
2011
221
0.080
Why?
Cognition Disorders
1
2011
213
0.080
Why?
Syndrome
1
2010
247
0.080
Why?
Cleft Palate
1
2011
80
0.080
Why?
Lymph Nodes
1
2010
253
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1365
0.070
Why?
Skin
1
2010
416
0.070
Why?
Myocardium
1
2010
471
0.070
Why?
Exercise
1
2010
559
0.060
Why?
Heart Defects, Congenital
1
2011
615
0.060
Why?
Obsessive-Compulsive Disorder
1
2024
40
0.050
Why?
Cardiomyopathies
1
2026
117
0.050
Why?
Double-Blind Method
1
2026
726
0.050
Why?
Delphi Technique
1
2024
66
0.050
Why?
Azo Compounds
1
2022
11
0.050
Why?
Pilot Projects
1
2024
725
0.050
Why?
Health Personnel
1
2024
255
0.050
Why?
Electrodiagnosis
1
2021
12
0.040
Why?
Genetic Association Studies
1
2021
124
0.040
Why?
Pyrimidines
1
2022
199
0.040
Why?
Homozygote
1
2018
58
0.040
Why?
Prospective Studies
1
2024
2436
0.040
Why?
Signal Transduction
1
2021
1724
0.030
Why?
Flurothyl
1
2013
1
0.030
Why?
Kindling, Neurologic
1
2013
3
0.030
Why?
Mice, Mutant Strains
1
2013
72
0.030
Why?
Aged, 80 and over
1
2021
3450
0.030
Why?
Animals, Newborn
1
2013
355
0.020
Why?
Protons
1
2012
74
0.020
Why?
Chi-Square Distribution
1
2012
292
0.020
Why?
Hippocampus
1
2013
231
0.020
Why?
Magnetic Resonance Spectroscopy
1
2012
249
0.020
Why?
Anisotropy
1
2011
60
0.020
Why?
Autoantibodies
1
2011
118
0.020
Why?
Drug Resistance
1
2011
69
0.020
Why?
Video Recording
1
2011
79
0.020
Why?
Neuropsychological Tests
1
2012
346
0.020
Why?
Sequence Homology, Amino Acid
1
2010
140
0.020
Why?
Diffusion Magnetic Resonance Imaging
1
2011
131
0.020
Why?
Exons
1
2010
101
0.020
Why?
Amino Acid Sequence
1
2010
576
0.020
Why?
Molecular Sequence Data
1
2010
778
0.020
Why?
Disease Models, Animal
1
2013
1483
0.020
Why?
Mice, Inbred C57BL
1
2013
1888
0.020
Why?
Case-Control Studies
1
2011
1201
0.020
Why?
Mice
1
2013
5899
0.010
Why?
Animals
1
2013
13485
0.010
Why?
Veerapandiyan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description